omniture
OLIX PHARMACEUTICALS INC.

Latest News

OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate

* Identified knockdown of target genes for the NASH treatment candidate * Reduction of ALT and A...

2022-04-08 20:00 2778

OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa

SUWON, South Korea, May 9, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a lea...

2019-05-10 09:24 1528

OliX Pharmaceuticals Announces The Ophthalmologist Demetrios G. Vavvas, M.D., Ph.D., to join Scientific Advisory Board

SUWON, South Korea, April 22, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a l...

2019-04-22 13:32 1556